Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03199911 · ClinicalTrials.gov registry record · Phase 4
Topical Antibiotic Prophylaxis for Eyelids
A Phase 4 study of Surgical Site Infection and Surgical Wound Infection, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 401
- Enrollment target
- 1
- Study location
NCT03199911: Completed Phase 4 study of Surgical Site Infection and Surgical Wound Infection, sponsored by University of California, San Francisco.
NCT03199911 is a Phase 4 study of Surgical Site Infection and Surgical Wound Infection that has completed, run by University of California, San Francisco. The registered enrollment target is 401 participants, below the 552-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03199911, a Phase 4 study of Surgical Site Infection and Surgical Wound Infection, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 401 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose a prospective randomized control trial testing the hypothesis that routine topical antibiotic prophylaxis does not significantly reduce the rate of infection after eyelid surgery.
Primary Outcome
The rate of superficial incisional or deep incisional surgical site infection (SSI) of clean and clean-contaminated wounds.
Conditions Studied
Interventions
- DRUG Topical Antibiotic Product
- DRUG Topical Non-Antibiotic Ointment
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2017-10-02 |
| Est. Completion | 2019-11-14 |
| Phase | Phase 4 |
What the finished NCT03199911 record still lists
NCT03199911 is an interventional study that assigns participants to a tested intervention. The registered 401 participants enrollment target is mid-sized for trials with a published cap, below the 552-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (27% lower).
The record links to 9 conditions, with Surgical Site Infection appearing as the primary indexed condition, and to 2 interventions - of which Topical Antibiotic Product is the first listed.
NCT03199911 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03199911 about?
NCT03199911 is a clinical study titled "Topical Antibiotic Prophylaxis for Eyelids". The investigators propose a prospective randomized control trial testing the hypothesis that routine topical antibiotic prophylaxis does not significantly reduce the rate of infection after eyelid surgery.
What is the current status of trial NCT03199911?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 401 participants. The study started on 2017-10-02. Estimated completion is 2019-11-14.
What conditions does trial NCT03199911 study?
This clinical trial studies the following conditions: Surgical Site Infection, Surgical Wound Infection, Surgical Incision, Antibiotic Allergy, Skin Cancer Face.
What interventions are being tested in trial NCT03199911?
The interventions under investigation include: Topical Antibiotic Product (DRUG), Topical Non-Antibiotic Ointment (DRUG).
Who is sponsoring clinical trial NCT03199911?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03199911 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Site Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03199911's enrollment target sits among peer trials
401 10th of 25 higher than 16 of 25 other Surgical Site Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgical Site Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
RECRUITING · Phase 4
-
Ostomy Primary Closure With 0.1% Betaine/Polyhexanide Wound Irrigation Compared to Pursestring Closure
RECRUITING · Phase 4
-
Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery
RECRUITING · Phase 4
-
PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)
ACTIVE NOT RECRUITING · Phase 4
-
Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures
COMPLETED · Phase 4
-
Multicenter Infection Surveillance Study Following Open Heart Surgery
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI